STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Y
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +23 more
- Lenalidomide
- +2 more
- Columbus, OhioOhio State University Comprehensive Cancer Center
2021-11-29
Nov 29, 2021N
Terminated
- Adult Grade III Lymphomatoid Granulomatosis
- +116 more
- brentuximab vedotin
- +2 more
- Chicago, Illinois
- +2 more
2021-08-30
Aug 30, 2021B
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
- Detroit, MichiganBarbara Ann Karmanos Cancer Institute
2021-04-14
Apr 14, 2021J
Recruiting
- Relapsed Plasmablastic Lymphoma
- +2 more
- Belantamab Mafodotin
- Boston, Massachusetts
- +2 more
2021-09-20
Sep 20, 2021B
Recruiting
- Diffuse Large B-Cell Lymphoma
- +14 more
- Ann Arbor, Michigan
- +2 more
2021-06-15
Jun 15, 2021D
Not yet recruiting
- Lymphoma
- Survivorship
- Interview with Clinicians
- +2 more
- Boston, MassachusettsDana-Farber Cancer Institute
2021-10-05
Oct 5, 2021W
Terminated
- Follicular Lymphoma
- Mantle Cell Lymphoma
- New York, New YorkWeill Cornell Medicine
2021-09-20
Sep 20, 2021U
Recruiting
- B-Cell Non-Hodgkin Lymphoma
- +7 more
- Acalabrutinib
- Axicabtagene Ciloleucel
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2021-09-07
Sep 7, 2021M
Recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +7 more
- Choline Salicylate
- Selinexor
- Rochester, MinnesotaMayo Clinic in Rochester
2021-08-23
Aug 23, 2021M
Withdrawn
- Lymphoma
- Home Hospital for Lymphoma
- Boston, MassachusettsMassachusetts General Hospital Cancer Center
2021-08-31
Aug 31, 2021N
Active, not recruiting
- Non-Hodgkin Lymphoma
- +4 more
- Pembrolizumab
- Bethesda, MarylandNational Institutes of Health Clinical Center
2021-09-02
Sep 2, 2021A
Not yet recruiting
- AIDS-Related Diffuse Large B-cell Lymphoma
- +14 more
- Axicabtagene Ciloleucel
- +2 more
- (no location specified)
2021-10-01
Oct 1, 2021C
Recruiting
- Grade 3b Follicular Lymphoma
- +15 more
- Laboratory Biomarker Analysis
- +2 more
- Duarte, CaliforniaCity of Hope Medical Center
2021-01-25
Jan 25, 2021M
Recruiting
- Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- +10 more
- External Beam Radiation Therapy
- Pembrolizumab
- Houston, TexasM D Anderson Cancer Center
2021-05-19
May 19, 2021D
Recruiting
- Grade 3a Follicular Lymphoma
- +14 more
- Laboratory Biomarker Analysis
- +2 more
- Atlanta, Georgia
- +1 more
2021-05-13
May 13, 2021U
Not yet recruiting
- Non-hodgkin Lymphoma
- +2 more
- Radiation - Dose Level 0
- +4 more
- (no location specified)
2021-08-20
Aug 20, 2021M
Active, not recruiting
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
- Scottsdale, Arizona
- +1 more
2021-10-06
Oct 6, 2021M
Completed
- Lymphoma
- 3RP-Lymphoma
- Boston, MassachusettsMassachusetts General Hospital
2021-11-09
Nov 9, 2021M
Active, not recruiting
- Ann Arbor Stage II Follicular Lymphoma
- +9 more
- Ibrutinib
- +3 more
- Houston, TexasM D Anderson Cancer Center
2021-11-16
Nov 16, 2021N
Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma
Not yet recruiting
- Recurrent Angioimmunoblastic T-Cell Lymphoma
- +13 more
- Brentuximab Vedotin
- Pembrolizumab
- Chicago, IllinoisNorthwestern University
2021-05-06
May 6, 2021B
Completed
- Marginal Zone Lymphoma
- +2 more
- Harbin, Heilongjiang, China
- +3 more
2021-10-26
Oct 26, 2021N
Completed
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +19 more
- ifosfamide
- +3 more
- Philadelphia, PennsylvaniaChildren's Oncology Group
2021-03-04
Mar 4, 2021N
Active, not recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +8 more
- Ibrutinib
- +2 more
- Chicago, Illinois
- +2 more
2021-08-25
Aug 25, 2021S
Not yet recruiting
- T-cell Lymphoma
- +10 more
- Chicago, IllinoisRush University Medical Center
2021-09-20
Sep 20, 2021M
Recruiting
- Aggressive Non-Hodgkin Lymphoma
- +9 more
- Cryosurgery
- +5 more
- Rochester, MinnesotaMayo Clinic in Rochester
2021-09-03
Sep 3, 2021